These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20604789)

  • 21. Pulmonary edema during cesarean section related to the use of oxytocic drugs.
    Heytens L; Camu F
    Acta Anaesthesiol Belg; 1984 Jun; 35(2):155-64. PubMed ID: 6593995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section.
    Mockler JC; Murphy DJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):30-5. PubMed ID: 20218994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxytocin should not be used to augment labour: FOR: there is too much risk for too little benefit.
    Steer PJ
    BJOG; 2015 Oct; 122(11):1543. PubMed ID: 26406259
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.
    Balki M; Dhumne S; Kasodekar S; Kingdom J; Windrim R; Carvalho JC
    BJOG; 2008 Apr; 115(5):579-84. PubMed ID: 18333937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A symposium: the cardiac arrhythmia suppression trial--does it alter our concepts of and approaches to ventricular arrhythmias? Woodland, Texas, August 9, 1989.
    Am J Cardiol; 1990 Jan; 65(4):1B-42B. PubMed ID: 2404393
    [No Abstract]   [Full Text] [Related]  

  • 26. [Case of anginal attack during caesarean section, with special reference to its relation to oxytocics].
    Innami H; Kawaguchi T
    Masui; 1968 May; 17(5):472-8. PubMed ID: 5749157
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-dose oral misoprostol for induction of labor: a systematic review.
    Kundodyiwa TW; Alfirevic Z; Weeks AD
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):374-83. PubMed ID: 19155909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstetric management and outcome of pregnancy in women with a history of caesarean section in the Netherlands.
    Kwee A; Bots ML; Visser GH; Bruinse HW
    Eur J Obstet Gynecol Reprod Biol; 2007 Jun; 132(2):171-6. PubMed ID: 16904813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intraoperative anaphylactic shock induced by methylergometrine and oxytocin].
    Shimo T; Nishiike S; Masuoka M; Seki S; Tsuchida H
    Masui; 2006 Apr; 55(4):447-50. PubMed ID: 16634548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic oxytocin and latex allergy.
    Ogata J; Minami K
    Br J Anaesth; 2007 Jun; 98(6):845-6. PubMed ID: 17519267
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of atropine and methotrimeprazine on the epinephrine-induced arrhythmias in halothane-anesthetized dogs.
    Neto FJ; Massone F; Luna SP; Camacho AA; Júnior JR; Ishiy HM
    Can J Vet Res; 2001 Apr; 65(2):116-24. PubMed ID: 11346256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin in active-phase abnormalities of labor: a randomized study.
    Cardozo L; Pearce JM
    Obstet Gynecol; 1990 Feb; 75(2):152-7. PubMed ID: 2405314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome in obstetric care related to oxytocin use. A population-based study.
    Oscarsson ME; Amer-Wåhlin I; Rydhstroem H; Källén K
    Acta Obstet Gynecol Scand; 2006; 85(9):1094-8. PubMed ID: 16929414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Willingness of pregnant women and clinicians to participate in a hypothetical randomised controlled trial comparing vaginal delivery and elective caesarean section.
    Turner CE; Young JM; Solomon MJ; Ludlow J; Benness C; Phipps H
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):542-6. PubMed ID: 19133040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine rupture in a patient with an unscarred uterus: a case study.
    Mazzone ME; Woolever J
    WMJ; 2006 Mar; 105(2):64-6. PubMed ID: 16628979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The AVID trial--another embarrassment.
    Nomof N
    Am J Cardiol; 1998 Feb; 81(4):530. PubMed ID: 9485153
    [No Abstract]   [Full Text] [Related]  

  • 39. Does a maximum dose of oxytocin affect risk for uterine rupture in candidates for vaginal birth after cesarean delivery?
    Cahill AG; Stamilio DM; Odibo AO; Peipert JF; Stevens EJ; Macones GA
    Am J Obstet Gynecol; 2007 Nov; 197(5):495.e1-5. PubMed ID: 17714683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial.
    Bricker L; Peden H; Tomlinson AJ; Al-Hussaini TK; Idama T; Candelier C; Luckas M; Furniss H; Davies A; Kumar B; Roberts J; Alfirevic Z
    BJOG; 2008 Nov; 115(12):1503-11. PubMed ID: 18752586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.